ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,212Medicare Part D Prescriptions Filled, Including Refills

Rank: 534 out of 6645

$532K Total Retail Price of All Prescriptions

Rank: 1058 out of 6645

431 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 568 540 1 2
OMEPRAZOLE 526 456 2 6
LISINOPRIL 489 449 3 3
GABAPENTIN 470 381 4 18
LEVOTHYROXINE SODIUM 437 406 5 4
PRAVASTATIN SODIUM 395 360 6 20
METFORMIN HCL 375 342 7 7
SIMVASTATIN 373 363 8 1
ATORVASTATIN CALCIUM 322 294 9 10
LOSARTAN POTASSIUM 291 278 10 12
FUROSEMIDE 282 269 11 11
RANITIDINE HCL 233 201 12 51
ATENOLOL 229 222 13 8
ALENDRONATE SODIUM 226 213 14 14
METOPROLOL TARTRATE 214 214 15 13
LOVASTATIN 202 202 16 15
PANTOPRAZOLE SODIUM 195 176 17 29
HYDROCODONE-ACETAMINOPHEN 192 163 S3 18 5
HYDROCHLOROTHIAZIDE 190 177 19 9
CITALOPRAM HBR 174 147 20 35
BENAZEPRIL HCL 145 145 21 21
SERTRALINE HCL 132 117 22 43
WARFARIN SODIUM 131 123 23 16
AZITHROMYCIN 130 112 24 44
TAMSULOSIN HCL 128 125 25 22
PAROXETINE HCL 111 92 26 72
CLOPIDOGREL 107 88 27 36
ISOSORBIDE MONONITRATE ER 106 106 28 66
CARVEDILOL 106 85 28 25
POTASSIUM CHLORIDE 101 96 30 28
HYDRALAZINE HCL 97 97 31 77
PROAIR HFA 89 80 32 32
TRAZODONE HCL 87 83 33 60
LIPITOR 85 59 34 69
DONEPEZIL HCL 85 85 34 27
FLUTICASONE PROPIONATE 84 80 36 26
PLAVIX 81 72 37 49
NAMENDA 80 80 38 41
ADVAIR DISKUS 72 64 39 45
FELODIPINE ER 69 69 40 105
FLUOXETINE HCL 69 38 40 63
LANTUS 69 50 40 50
SYNTHROID 69 31 40 79
FLOVENT HFA 67 66 44 293
CIPROFLOXACIN HCL 66 61 45 67
DIOVAN 65 65 46 19
INSULIN SYRINGE 65 52 46 61
KLOR-CON 8 64 64 48 123
ESCITALOPRAM OXALATE 61 50 49 86
MUPIROCIN 61 53 49 294
HUMALOG 59 58 51 137
ALLOPURINOL 57 51 52 31
ZOLPIDEM TARTRATE 54 51 53 17
COMBIVENT 52 52 54 174
SPIRIVA 51 42 55 65
NIFEDIPINE ER 50 48 56 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.